These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21654725)

  • 21. A brief guide to understanding patentability and the meaning of patents.
    Elliott GC
    Acad Med; 2002 Dec; 77(12 Pt 2):1309-14. PubMed ID: 12480641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Israeli doctors want to stop European patent for genetic test.
    Siegel-Itzkovich J
    BMJ; 2005 Jul; 331(7507):8. PubMed ID: 15994669
    [No Abstract]   [Full Text] [Related]  

  • 23. Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?
    Komatani TS
    Pharm Pat Anal; 2015; 4(5):357-62. PubMed ID: 26451906
    [No Abstract]   [Full Text] [Related]  

  • 24. From Bilski back to Benson: preemption, inventing around, and the case of genetic diagnostics.
    Dreyfuss R; Evans JP
    Stanford Law Rev; 2011 Jun; 63(6):1349-76. PubMed ID: 21774194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patentability of genetically engineered microorganisms.
    Cooper A
    JAMA; 1983 Mar; 249(12):1553-4. PubMed ID: 6338261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of synthetic biology on patent law in view of of European jurisprudence].
    Bernardo Alvarez MA
    Rev Derecho Genoma Hum; 2014; (41):123-40. PubMed ID: 25845209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilski: assessing the impact of a newly invigorated patent-eligibility doctrine on the pharmaceutical industry and the future of personalized medicine.
    Holman CM
    Curr Top Med Chem; 2010; 10(18):1937-49. PubMed ID: 20615185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethical questions to ponder in the European stem cell patent debate.
    Curley D; Sharples A
    J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basics of US patents and the patent system.
    Elliott G
    AAPS J; 2007 Aug; 9(3):E317-24. PubMed ID: 17915834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions.
    Pillai X; Kinney WA
    Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patent protection for structural genomics-related inventions.
    Vinarov SD
    J Struct Funct Genomics; 2003; 4(2-3):191-209. PubMed ID: 14649303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patenting inventions in the field of biology and chemistry: German and European patent law and case law.
    Vossius V
    Naturwissenschaften; 1997 Oct; 84(10):431-43. PubMed ID: 9394296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The European opposition against the BRCA gene patents.
    Matthijs G
    Fam Cancer; 2006; 5(1):95-102. PubMed ID: 16528613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patenting genetic diagnostic methods: NGS, GWAS, SNPs and patents.
    Lawson C
    J Law Med; 2015 Jun; 22(4):846-63. PubMed ID: 26349382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic patenting and the utility requirement.
    Calvert J
    New Genet Soc; 2004 Dec; 23(3):301-12. PubMed ID: 15828153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patentability of genes: a European Union perspective.
    Cole P
    Cold Spring Harb Perspect Med; 2014 Oct; 5(5):a020891. PubMed ID: 25324232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of a recent court challenge to the protection of biomarkers as intellectual property.
    Hall SC; Tromp JM; Jortani SA
    Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Revocation of the BRCA1 patents by the European Office of Patents: a victory over a rights abuse].
    Stoppa-Lyonnet D; Lenoir G
    Bull Cancer; 2005 Apr; 92(4):410-1. PubMed ID: 15888396
    [No Abstract]   [Full Text] [Related]  

  • 40. Trends in the human embryonic stem cell patent field.
    Karlsson U; Hyllner J; Runeberg K
    Recent Pat Nanotechnol; 2007; 1(3):233-7. PubMed ID: 19076035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.